Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA307753
Max Phase: Preclinical
Molecular Formula: C25H30O13
Molecular Weight: 538.50
Molecule Type: Small molecule
Associated Items:
ID: ALA307753
Max Phase: Preclinical
Molecular Formula: C25H30O13
Molecular Weight: 538.50
Molecule Type: Small molecule
Associated Items:
Synonyms (1): L-731078
Synonyms from Alternative Forms(1):
Canonical SMILES: C=C(CCC12OC(C(=O)O)C(O)(C(=O)O)C(C(=O)O)(O1)[C@H](O)[C@H]2O)[C@@H](OC(C)=O)[C@H](C)Cc1ccccc1
Standard InChI: InChI=1S/C25H30O13/c1-12(16(36-14(3)26)13(2)11-15-7-5-4-6-8-15)9-10-23-17(27)18(28)25(38-23,22(33)34)24(35,21(31)32)19(37-23)20(29)30/h4-8,13,16-19,27-28,35H,1,9-11H2,2-3H3,(H,29,30)(H,31,32)(H,33,34)/t13-,16-,17-,18-,19?,23?,24?,25?/m1/s1
Standard InChI Key: RUIMBWGGEYKRPS-RFYBCTDESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 538.50 | Molecular Weight (Monoisotopic): 538.1686 | AlogP: -0.30 | #Rotatable Bonds: 11 |
Polar Surface Area: 217.35 | Molecular Species: ACID | HBA: 10 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.72 | CX Basic pKa: | CX LogP: 1.09 | CX LogD: -7.93 |
Aromatic Rings: 1 | Heavy Atoms: 38 | QED Weighted: 0.16 | Np Likeness Score: 1.82 |
1. Shaw RE, Burgess C, Cousins RP, Giblin GM, Livermore DG, Shingler AH, Smith C, Youds PM. (1994) Synthesis of novel monocyclic squalestatin analogues as potential inhibitors of squalene synthase, 4 (18): [10.1016/S0960-894X(00)80062-1] |
2. Harris GH, Dufresne C, Joshua H, Koch LA, Zink DL, Salmon PM, Goklen KE, Kurtz MM, Rew DJ, Bergstrom JD, Wilson KE. (1995) Isolation, structure determination and squalene synthase activity of L-731,120 and L-731,128, alkyl citrate analogs of zaragozic acids A and B, 5 (20): [10.1016/0960-894X(95)00419-T] |
3. Ponpipom MM, Girotra NN, Bugianesi RL, Roberts CD, Berger GD, Burk RM, Marquis RW, Parsons WH, Bartizal KF, Bergstom JD.. (1994) Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives., 37 (23): [PMID:7966163] [10.1021/jm00049a022] |
Source(1):